Low-density lipoprotein cholesterol is predominantly associated with atherosclerotic cardiovascular disease events in patients with evidence of coronary atherosclerosis: The Western Denmark Heart Registry.
Mortensen MB, Dzaye O, Bøtker HE, Jensen JM, Maeng M, Bentzon JF, Kanstrup H, Sørensen HT, Leipsic J, Blankstein R, Nasir K, Blaha MJ, Nørgaard BL
Evaluation of lipoprotein(a) in the prevention and management of atherosclerotic cardiovascular disease: A survey among the Lipid Clinics Network.
Catapano AL, Tokgözoğlu L, Banach M, Gazzotti M, Olmastroni E, Casula M, Ray KK; Lipid Clinics Network Group
Variability in lipid levels and risk for cardiovascular disease: an electronic health record-based population cohort study.
J Am Heart Assoc. 2023;12:e027639
Manemann SM, Bielinski SJ, Moser ED, St Sauver JL, Takahashi PY, Roger VL, Olson JE, Chamberlain AM, Remaley AT, Decker PA, Killian JM, Larson NB
Association between triglycerides and incident cognitive impairment in black and white adults in the reasons for geographic and racial differences in stroke study.
J Am Heart Assoc. 2023;12:e026833
Rosenson RS, Cushman M, McKinley EC, Muntner P, Wang Z, Vaisar T, Heinecke J, Tangney C, Judd S, Colantonio LD
The global syndemic of metabolic diseases in the young adult population: A consortium of trends and projections from the Global Burden of Disease 2000-2019.
Chong B, Kong G, Shankar K, Chew HSJ, Lin C, Goh R, Chin YH, Tan DJH, Chan KE, Lim WH, Syn N, Chan SP, Wang JW, Khoo CM, Dimitriadis GK, Wijarnpreecha K, Sanyal A, Noureddin M, Siddiqui MS, Foo R, Mehta A, Figtree GA, Hausenloy DJ, Chan MY, Ng CH, Muthiah M, Mamas MA, Chew NWS
Comparative associations of nonalcoholic fatty liver disease and metabolic dysfunction-associated fatty liver disease with coronary artery calcification: a cross-sectional and longitudinal cohort study.
Arterioscler Thromb Vasc Biol. 2023;43:482-491
Sung KC, Yoo TK, Lee MY, Byrne CD, Zheng MH, Targher G